Gan & Lee Pharmaceuticals. (603087.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 40.33B |
| Enterprise Value | 38.37B |
| P/E Ratio | 34.2 |
| PEG Ratio | 1.36 |
| Price/Sales Ratio | 9.43 |
| Price/Book Ratio | 3.37 |
| Enterprise/Revenue | 8.88 |
| Enterprise/EBITDA | 37.71 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.27 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.1 |
Income Statement
| Revenue | 4.04B |
| Revenue/Share | 7.09 |
| Gross Profit | 2.94B |
| EBITDA | 1.07B |
| Net Income | 1.14B |
| Diluted EPS | 1.93 |
Balance Sheet
| Total Cash | 3.96B |
| Total Cash/Share | 6.66 |
| Total Debt | 210.68M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 6.91 |
| Book Value Per Share | 19.76 |
Price History
| 52-Week Change | -10.87 |
| 52-Week High | 82.25 |
| 52-Week Low | 51.51 |
| Moving Average 50 Days | 68.75 |
| Moving Average 200 Days | 64.18 |
Statistics
| Average Volume | 12.31M |
| Shares Outstanding | 597.93M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 1.51 |
| Payout Ratio | 0.52 |
| Last Split Factor | 7:5 |
| Last Split Date | August 20, 2020 |
AD
